Literature DB >> 10677588

Expression of nitric oxide-sensitive guanylyl cyclase subunits in human corpus cavernosum.

S Behrends1, A Steenpass, H Porst, H Scholz.   

Abstract

The muscles of the corpus cavernosum of the penis relax in response to stimulation of non-adrenergic, non-cholinergic nerves or nitric oxide (NO)-donating drugs to elicit erection. It is generally assumed that NO mediates this effect via activation of soluble guanylyl cyclase and a subsequent increase in cyclic guanosine 3', 5'-monophosphate concentration. However, there are no data on the expression of this enzyme in human corpus cavernosum. The purpose of the present study was the molecular characterization of NO-sensitive guanylyl cyclase in human corpus cavernosum. RNA was extracted from tissue samples obtained from seven patients undergoing penile prosthetic surgery or correction of penile deviation. Reverse transcriptase-polymerase chain reaction (RT-PCR) with specific primers for the subunits of NO-sensitive guanylyl cyclase was performed, and PCR products were subcloned and sequenced. Specific amplification products encoding the alpha(1), beta(1), alpha(2), and beta(2) subunits were detected. In addition, we isolated a transcript encoding a novel variant beta(2) subunit. To test whether this novel transcript arises by alternative splicing or whether it is encoded by a separate gene, a 4000-bp clone of the corresponding genomic DNA sequence was isolated. Sequence analysis suggests that the novel beta(2) variant arises by alternative splicing from the same gene as the beta(2) subunit on chromosome 13. In conclusion, our findings suggest the presence of different subunit mRNAs of NO-sensitive guanylyl cyclase in human corpus cavernosum.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10677588     DOI: 10.1016/s0006-2952(99)00381-0

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  5 in total

Review 1.  Stimulators and activators of soluble guanylate cyclase for urogenital disorders.

Authors:  Fabiola Z Mónica; Edson Antunes
Journal:  Nat Rev Urol       Date:  2017-11-14       Impact factor: 14.432

Review 2.  RNA splicing in regulation of nitric oxide receptor soluble guanylyl cyclase.

Authors:  Iraida G Sharina; Gilbert J Cote; Emil Martin; Marie-Francoise Doursout; Ferid Murad
Journal:  Nitric Oxide       Date:  2011-08-16       Impact factor: 4.427

3.  Alternative splicing impairs soluble guanylyl cyclase function in aortic aneurysm.

Authors:  Emil Martin; Eva Golunski; Susan T Laing; Anthony L Estrera; Iraida G Sharina
Journal:  Am J Physiol Heart Circ Physiol       Date:  2014-09-19       Impact factor: 4.733

4.  Silencing MaxiK activity in corporal smooth muscle cells initiates compensatory mechanisms to maintain calcium homeostasis.

Authors:  Giulia Calenda; Sylvia Ottilie Suadicani; Rodolfo Iglesias; David Conover Spray; Arnold Melman; Kelvin Paul Davies
Journal:  J Sex Med       Date:  2011-01-26       Impact factor: 3.802

5.  Genomic organization of alpha1 and beta1 subunits of the mammalian soluble guanylyl cyclase genes.

Authors:  I G Sharina; J S Krumenacker; E Martin; F Murad
Journal:  Proc Natl Acad Sci U S A       Date:  2000-09-26       Impact factor: 11.205

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.